How is Epigenetic Research Advancing Cancer Diagnosis?
Epigenetic biomarkers are increasingly being used for the early diagnosis and prognosis of cancer. Techniques such as bisulfite sequencing and methylation-specific PCR can detect aberrant DNA methylation patterns in bodily fluids, providing non-invasive methods for early cancer detection. For example, the hypermethylation of the MGMT gene is a biomarker for glioblastoma.
